[2014 May] Rearranging the Deck Chairs on the Deck of the MHRA (UK FDA) By Martin Walker
As to Andrew Pollard as recently as 2009 when advocating the introduction of Hep B vaccine on to the infant schedule (which mercifully until now our children have been spared) he disclosed in BMJ as his competing interests:
"Competing interests: AJP conducts clinical trials on behalf of Oxford University, sponsored by GlaxoSmithKline Vaccines, Novartis Vaccines, Sanofi Pasteur, Sanofi Pasteur MSD, and Wyeth Vaccines and has received funds from vaccine manufacturers to attend scientific meetings. The University of Oxford has received unrestricted grants for educational meetings organised by AJP. Industry sourced honorariums for lecturing or writing are paid directly to an independent charity or an educational/administrative fund held by the department of paediatrics, University of Oxford."